Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2008
11/19/2008EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor
11/19/2008EP1991526A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
11/19/2008EP1991278A2 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity
11/19/2008EP1307226B1 Vitronectin receptor antagonist pharmaceuticals
11/19/2008EP1112084B1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
11/18/2008CA2373993C Site specific binding system, nuclear imaging compositions and methods
11/18/2008CA2334146C Radioiodinated phenols for brachytherapy
11/18/2008CA2287781C Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
11/18/2008CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/18/2008CA2107884C Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
11/13/2008WO2008136850A2 Cobalamin conjugates useful as imaging and therapeutic agents
11/13/2008WO2008134876A1 Cancerous disease modifying antibodies
11/13/2008WO2008113792A3 Production of thorium 228 starting from a natural thorium salt
11/13/2008WO2008028688A3 Compounds and methods for 18f labeled agents
11/13/2008WO2007123934A3 Aryl bidentate isonitriles and their uses
11/13/2008WO2006017251A3 Compositions for delivering peptide yy and pyy agonists
11/13/2008US20080281166 Methods and systems for assessing gastric emptying
11/13/2008US20080281086 Fluorous coating on support for dispensing fluorous reaction product; polytetrafluoroethylene or fluoropolymer tape; depositing on support using solvent; evaporation of solvent
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080279774 Perturbed Membrane-Binding Compounds And Methods Of Using The Same
11/13/2008US20080279773 Skeletal-targeted radiation to treat bone-associated pathologies
11/13/2008US20080279772 Generation of therapeutic radioconjugate; load isotope onto binding support, elute long lived isotopes, join isotope to targeting particle, recover radioconjugate
11/13/2008US20080279771 Novel Imaging Agents for Cancer
11/13/2008US20080279770 Metal Complexes Based on Tetrathiol Ligands and Their Use in Nuclear Medical Diagnostics and Endoradionuclide Therapy and Method For Producing Said Metal Complexes
11/13/2008US20080279769 Enzyme Inhibitor Imaging Agents
11/13/2008US20080279768 Bifunctional Metal Chelating Conjugates
11/13/2008US20080279767 Cancerous disease modifying antibodies
11/13/2008US20080279766 analyzing a sample from a subject for the presence of a distinguishable agent such as cholate and applying information obtained from analyzing the presence of the distinguishable agent to determine a treatment
11/13/2008US20080279765 targeting the mannose-6-phosphate (M6P) receptor suitable for the non-invasive visualization
11/13/2008CA2684906A1 Cancerous disease modifying antibodies
11/12/2008EP1988925A2 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
11/12/2008CN101305006A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
11/12/2008CN101301496A Biodegradable and absorbable polymer superfine fibre film with radioactive nuclide marker and preparation and use thereof
11/11/2008US7449445 Conductive peptide nanofiber and method of manufacture of the same
11/11/2008US7449171 Measurement biosynthesis of metabolism product; isotopes labeled
11/11/2008US7449170 Materials and methods for controlling isotope effects during fractionation of analytes
11/06/2008WO2008134662A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/06/2008WO2008134618A2 Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders
11/06/2008WO2008134525A1 Deuterium labelled ketamine
11/06/2008WO2008134289A2 High relaxivity coordinatively unsaturated lanthanide complexes
11/06/2008WO2008133730A2 Labeled rotenone analogs
11/06/2008WO2008132211A1 Amino-quinazolinone derivatives for use as radiotracers and imaging agents
11/06/2008WO2008106507A3 Mdm2/mdmx inhibitor peptide
11/06/2008WO2008105773A3 System for targeted delivery of therapeutic agents
11/06/2008WO2008070464A3 Methods of imaging employing chelating agents
11/06/2008WO2008070336A3 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
11/06/2008WO2008068717A3 A system, method, computer-readable medium, and use for planning combined therapy
11/06/2008WO2008024830A3 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers
11/06/2008WO2007140059A3 High molecular weight chelation structure
11/06/2008US20080274053 Determining risk of tissue damage in ischemic tissue by administering a diagnostic imaging agent containing oxygen-17 in carrier (blood) and comparing the oxygen extraction fraction of a first tissue zone to the extraction fraction of a second tissue zone using proton magnetic resonance imaging
11/06/2008US20080274052 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide
11/06/2008US20080274051 Diagnosis and Treatment of Mood Disorders
11/06/2008US20080274050 Labelled Adrenomedullin Derivatives and Their Use for Imaging and Therapy
11/06/2008US20080274049 Cytotoxicity mediation of cells evidencing surface expression of CD44
11/06/2008US20080274048 kit comprising an antioxidant such as ascorbic acid, p-aminobenzoic acid, cysteine, monothioglycerol, or gentisic acid covalently bound to a radiopharmaceutical ligand; optional targeting molecule
11/06/2008US20080274047 producing antibodies which bind NK cell receptors for use in therapeutic strategies for treating immunoproliferative and autoimmune disorders
11/06/2008US20080274046 Radiolabelling
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008US20080274044 aqueous dispersion comprising insoluble therapeutic or diagnostic agent particles having a surface modifier; treating a respiratory illness
11/06/2008CA2685344A1 Deuterium labelled ketamine
11/05/2008EP1987017A1 Radioligands for the 5 -ht1b receptor
11/05/2008EP1986700A2 The staudinger reaction in imaging and therapy and kits for use in imaging and therapy
11/05/2008EP1742670B1 Radium target and method for producing it
11/05/2008EP1345630B1 Stabilised radiopharmaceutical compositions
11/05/2008EP1109937B1 METHOD OF DIAGNOSING, MONITORING, STAGING, and IMAGING VARIOUS CANCERS
11/05/2008CN101300033A Treatment and prevention of adverse liver conditions using gallium
11/04/2008US7447340 Device and method for automatically producing a thermal recoil response in nematodes
11/04/2008US7445765 Active ingredient a technetium-99m nitride heterocomplex comprising technetium-99m nitride and two different ligands coordinated therewith, i.e., a bisphosphinoamine compound as a pi electron acceptor and a bidentate ligand as a pi electron
11/04/2008US7445764 Carrier-drug conjugate
11/04/2008US7445628 Method of treating a patient with a coated implantable medical device
11/04/2008CA2223432C Radiometal-binding analogues of luteinizing hormone releasing hormone
10/2008
10/30/2008WO2008129928A1 Biomolecule labeling reagent, and biomolecule detection system using the same
10/30/2008WO2008098056A3 High relaxivity chelates
10/30/2008WO2008075966A9 Synthesis of a radiofluorinated peptide using photolabile protecting groups
10/30/2008WO2008051416A3 Compounds that inhibit the activity of hsp90 for treating infections
10/30/2008WO2008050255A3 Contrast agents for detecting prostate cancer
10/30/2008WO2007115132A3 Radiopharmaceutical in self-forming liposomal formulation capable of multipath administration including other ingredients
10/30/2008WO2007024715A3 Dual variable domain immunoglobin and uses thereof
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080267950 Molecular determinants of myeloma bone disease and uses thereof
10/30/2008US20080267879 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267875 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
10/30/2008US20080267870 1-[(2'-Substituted)-piperazin-1' -yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
10/30/2008US20080267869 Technetium- or rhenium-imido group, strongly stabilized by presence of two ancillary tridentate and bidentate hetero-diphosphine ligands; radiodiagnostic imaging and radiotherapy
10/30/2008US20080267868 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
10/30/2008US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment
10/30/2008US20080267866 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/30/2008US20080267865 Targeting of Erb Antigens
10/30/2008US20080267864 Cancerous disease modifying antibodies
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008US20080267861 Myocardial Perfusion Imaging
10/29/2008EP1985624A2 Single step method of radiofluorination of biologically active compounds or biomolecules
10/29/2008EP1985320A1 A multi-formed collagenous biomaterial medical device
10/29/2008EP1985313A1 Positron tomography method and positron-emitting compound to be used therein
10/29/2008EP1749026A4 Labelled adrenomedullin derivatives and their use for imaging and therapy
10/29/2008EP1514105B1 Methods of modulating tubulin deacetylase activity
10/29/2008EP1492776B1 Iodinated triglyceride analogs
10/29/2008EP1483399B1 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 243